Development of an Fn14 agonistic antibody as an anti-tumor agent.
Michaelson JS, Amatucci A, Kelly R, Su L, Garber E, Day ES, Berquist L, Cho S, Li Y, Parr M, Wille L, Schneider P, Wortham K, Burkly LC, Hsu YM, Joseph IB.
Michaelson JS, et al. Among authors: parr m.
MAbs. 2011 Jul-Aug;3(4):362-75. doi: 10.4161/mabs.3.4.16090. Epub 2011 Jul 1.
MAbs. 2011.
PMID: 21697654
Free PMC article.